Belgian telecoms: Telenet increases its fixed internet speed at unchanged price Colruyt: FY25/26F profitability guidance maintained despite market share loss Corbion: Keep Calm and Carry On Fagron: Acquires UCP, adding to its 503A health and wellness offering in California GBL: Planning ahead to deliver on its promise OCI: Limited details on Orascom merger, sales process for Nitrogen Europe ongoing TKH Group: Mixed emotions Wolters Kluwer: Launches UpToDate Expert AI
After BASF has gradually lifted Force Majeure status on its vitamin operations in the past few months, vitamin prices have normalized quickly and the temporary pricing benefit dsm-firmenich enjoyed is now about to come to an end. As we were previously still banking on a more gradual normalization and still a bit of benefit in 2026, we have now adjusted our forecasts. We expect dsm-firmenich to still announce an ANH divestment in the near term and bank on a deal value of c. € 4bn. Taking into acc...
During the AGM, Colruyt reiterated its outlook, aiming to match the EBIT and net result of last year. This translates into an EBIT of € 470m and net profit of € 350m as the French activities will be classified as discontinued operations. Note that the outlook excludes any potential one-offs (France restructuring and Foodbag). However, Colruyt added that it expects an EBIT decline in 1H, which will be offset in 2H. While the group reiterated that the environment remains challenging, Colruyt menti...
DEME awarded substantial contract for Formosa 4 offshore wind farm in Taiwan DEME, through its Taiwanese joint venture CDWE, has secured a substantial contract for the Formosa 4 offshore wind farm in Taiwan, covering the transport and installation of 35 foundations and the offshore substation, as well as the scour protection works. Attachment
DEME haalt substantieel contract binnen voor Formosa 4 offshore windpark in Taiwan DEME heeft, via zijn Taiwanese joint venture CDWE, een substantieel contract binnengehaald voor het offshore windpark Formosa 4 in Taiwan. Het contract omvat het transport en de installatie van 35 funderingen en het offshore substation, evenals de werkzaamheden voor erosiebescherming. Bijlage
Fagron announces the acquisition of UCP in North America and FDA inspection update Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 25 September 2025 – 7:00 AM CET Fagron announces the acquisition of UCP in North America and FDA inspection update Fagron, the leading global player in pharmaceutical compounding, is pleased to announce a strategic acquisition that will significantly reinforce its presence in North America. The company has signed the acquisition of University Compounding Pharmacy (UCP), a 503A pharmaceutical compounder specializing in...
Fagron kondigt de overname van UCP in Noord-Amerika aan en een update over de FDA-inspectie Gereglementeerde informatie - voorkennisNazareth (België)/Rotterdam (Nederland), 25 september 2025 – 07.00 uur CET Fagron kondigt de overname van UCP in Noord-Amerika aan en een update over de FDA-inspectie Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, kondigt met genoegen een strategische overname aan, die de positie van het bedrijf in Noord-Amerika aanzienlijk zal verstevigen. Het bedrijf heeft voor de overname van University Compounding Pharmacy (UCP), een farmaceut...
Ackermans & van Haaren invests 22 million euros in VKC Nuts Dear shareholder, Dear Madam, Dear Sir, Ackermans & van Haaren (AvH) has entered into an agreement to invest 22 million euros in VKC Nuts Private Limited (VKC Nuts), a leading family business in the fast-growing nuts and dried fruits sector in India. Upon closing of this investment, which is expected in the fourth quarter of this year, AvH will hold a 16.6% stake in VKC Nuts and be represented on its board of directors. Please find attached the full press release. Best regards Ackermans & van Haaren Attachment ...
Ackermans & van Haaren investit 22 millions d'euros dans VKC Nuts Cher actionnaire, Monsieur, Madame, Ackermans & van Haaren (AvH) a conclu un accord en vue d’investir 22 millions d’euros dans VKC Nuts Private Limited (VKC Nuts), une entreprise familiale leader du marché dans le secteur en forte croissance des fruits à coque et fruits secs en Inde. À l’issue de cette opération, dont le closing est attendu au quatrième trimestre de cette année, AvH détiendra une participation de 16,6 % dans VKC Nuts et sera représentée au sein de son conseil d’administration. Veuillez trouver ci-joint l...
Ackermans & van Haaren investeert 22 miljoen euro in VKC Nuts Geachte aandeelhouder, Geachte mevrouw, geachte heer, Ackermans & van Haaren (AvH) heeft een overeenkomst gesloten om 22 miljoen euro te investeren in VKC Nuts Private Limited (VKC Nuts), een toonaangevende familiale onderneming op de snelgroeiende Indiase markt voor noten en gedroogd fruit. Na afronding van deze investering, die wordt verwacht in het vierde kwartaal van dit jaar, zal AvH een belang van 16,6% verwerven in VKC Nuts en vertegenwoordigd zijn in de raad van bestuur. Gelieve bijgevoegd het volledige persbericht t...
KBC Securities will host its annual life sciences conference on 25 September in Brussels. The event will include 14 exciting companies, both public and private, from the BeNeLux ecosystem and beyond. In this conference note, we provide an overview of the attending companies, as well as an outlook on KBC Securities' life sciences broader coverage.
Weekly progress on share repurchase program to cover share plans and reduce capital Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), September 23, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 13, 2025 its intention to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital, starting with an initial €500 million. On April 1, 2025, the company commenced a program to repurchase ordinary shares for a tota...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.